Zobrazeno 1 - 5
of 5
pro vyhledávání: '"REDISSEC-CaMISS Group"'
Autor:
Irene Zarcos‐Pedrinaci, Maximino Redondo, Javier Louro, Francisco Rivas‐Ruiz, Teresa Téllez, Diego Pérez, Francisco Medina Cano, Kenza Machan, Laia Domingo, Maria Mar Vernet, Maria Padilla‐Ruiz, Xavier Castells, Antonio Rueda, María Sala, REDISSEC‐CaMISS Group
Publikováno v:
Cancer Medicine, Vol 8, Iss 15, Pp 6662-6670 (2019)
Abstract The aim of this study is to determine the survival of patients with breast cancer treated with adjuvant chemotherapy (ACh) after the diagnosis by screening, taking comorbidity into account. This multicenter cohort study examined a population
Externí odkaz:
https://doaj.org/article/741a012f4e354209ac26ba6ab7e00aec
Autor:
Miret, Carme, Orive, Miren, Sala, Maria, García Gutiérrez, Susana, Sarasqueta, Cristina, Legarreta, Maria José, Redondo, Maximino, Rivero, Amado, Castells, Xavier, Quintana, José María, Garin Boronat, Olatz, 1979, Ferrer Forés, Maria Montserrat, REDISSEC-CaMISS Group
Publikováno v:
Quality of Life Research. 32:989-1003
Purpose To obtain reference norms of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L, based on a population of Spanish non-metastatic breast cancer patients at diagnosis and 2 years after, according to relevant demographic and clinical characteristics. M
Autor:
García-Gutierrez, Susana, Orive, Miren, Sarasqueta, Cristina, Legarreta Olabarrieta, María José, Gonzalez, Nerea, Redondo, Maximino, Rivero, Amado, Serrano-Aguilar, Pedro, Castells, Xavier, Quintana López, José María, Sala, Maria, REDISSEC-CaMISS group
Publikováno v:
Addi. Archivo Digital para la Docencia y la Investigación
instname
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
BMC Cancer
instname
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
BMC Cancer
Background: Though breast cancer remains a major health problem, there is a lack of information on health care provided to patients with this disease and associated costs. In addition, there is a need to update and validate risk stratification tools
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3362e22df94d42555c09fb961a619324
http://hdl.handle.net/10810/32347
http://hdl.handle.net/10810/32347
Autor:
Zarcos-Pedrinaci, Irene, Redondo, Maximino, Louro, Javier, Rivas Ruiz, Francisco, Téllez, Teresa, Pérez, Diego, Medina Cano, Francisco, Machan, Kenza, Domingo, Laia, Vernet-Tomás, Maria, Padilla-Ruiz, Maria, Castells, Xavier, Rueda, Antonio, Sala Serra, Maria, REDISSEC-CaMISS Group
Publikováno v:
Cancer Medicine, Vol 8, Iss 15, Pp 6662-6670 (2019)
Cancer Medicine
Cancer Medicine
The aim of this study is to determine the survival of patients with breast cancer treated with adjuvant chemotherapy (ACh) after the diagnosis by screening, taking comorbidity into account. This multicenter cohort study examined a population of patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90430f1d7a0faa7b4f56628fd4ef2623
http://hdl.handle.net/10230/42927
http://hdl.handle.net/10230/42927
Autor:
Susana García-Gutierrez, Miren Orive, Cristina Sarasqueta, Maria Jose Legarreta, Nerea Gonzalez, Maximino Redondo, Amado Rivero, Pedro Serrano-Aguilar, Xavier Castells, Jose Maria Quintana, Maria Sala, on behalf of REDISSEC-CaMISS group
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Though breast cancer remains a major health problem, there is a lack of information on health care provided to patients with this disease and associated costs. In addition, there is a need to update and validate risk stratificatio
Externí odkaz:
https://doaj.org/article/496909b0a29f423e96ba58ca6d33d39d